Fluvirin Related Clinical Trials
School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities [Completed]
Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects [Completed]
Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM [Completed]
A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 [Completed]
Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults [Completed]
Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years [Completed]
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects [Completed]
Study of Quadrivalent Influenza Vaccine Among Adults [Completed]
A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults [Completed]
2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women [Completed]
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects [Completed]
Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation. [Completed]
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults [Completed]
A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age [Completed]
Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021)- Year 1, 2011 [Active, not recruiting]
Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study [Completed]
Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years [Completed]
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children [Completed]
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program [Active, not recruiting]
Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy [Active, not recruiting]
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine [Active, not recruiting]
FluMist in Egg Allergic Patients [Recruiting]
Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza [Completed]
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Children [Completed]
Evaluate Reactogenicity and Immunogenicity of Standard-dose (SD) Versus High-dose (HD) Inactivated Influenza Vaccine Trivalent (IIV3) in Recipients of Solid Organ Transplants. [Recruiting]
B-cell Immunity to Influenza (SLVP017)- Year 1, 2009 [Active, not recruiting]
Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine [Completed]
Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older [Completed]
Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents [Completed]
Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants [Completed]
Analysis of Bone Marrow and Blood B Cell Immune Responses to Influenza Vaccination [Not yet recruiting]
Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children [Completed]
Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4 [Completed]
Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine [Completed]
Immunogenicity and Safety Study to Assess Influenza Vaccine Formulated With Haemagglutinin (HA) Antigen From Two Suppliers [Completed]
Influenza and Text Messaging in Pregnancy [Completed]
Immunogenicity & Safety Study of Fluviral® (2010 - 2011 Season) in Adults Aged 18 to 60 Years and Over 60 Years [Completed]
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Fluviral® (2012/2013 Season) in Adults [Completed]
Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above [Completed]
Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age [Completed]
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1) [Completed]
Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya [Withdrawn]
Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza Vaccine [Not yet recruiting]
Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults. [Completed]
The Effect of Proximity on Flu-Shot Participation [Completed]
Comparison of 4 Influenza Vaccines in Seniors [Completed]
Cell Mediated Immunity in Older Adults [Completed]
Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally [Completed]
Hutterite Influenza Prevention Study [Completed]
A Study to Evaluate the Safety and Immune Responses to Fluzone� Vaccination [Completed]
Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age [Completed]
Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers [Recruiting]
Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation) [Completed]
Comparison of Flu Vaccine Doses in Children [Completed]
Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines [Completed]
Study to Evaluate Impact of School-based Influenza Vaccination on School Populations [Completed]
Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus [Completed]
Safety and Immunogenicity of MF59C.1 Adjuvanted Trivalent Subunit Influenza Vaccine in Elderly Subjects [Completed]
Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children [Active, not recruiting]
Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/B [Not yet recruiting]
Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York [Not yet recruiting]
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults [Completed]
A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years [Completed]
Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly [Completed]
Safety and Immunogenicity of a Cell Culture-derived Influenza Vaccine in Healthy Adults and Elderly [Completed]
Cholecalciferol and Flu Vaccine in Treating Healthy Participants [Terminated]
Collaborative Efforts to Increase Flu Vaccination [Completed]
Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics [Completed]
Inactivated Influenza Vaccine Effectiveness in Tropical Africa [Completed]
Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy Adults [Completed]
Influenza Vaccine Post Allogeneic Transplant [Terminated]
Safety and Immunogenicity of a Single Dose of Intranasal Seasonal Trivalent Live-Attenuated Influenza Vaccine [Completed]
Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children [Completed]
Sanofi H1N1 + TIV - Adults and Elderly [Completed]
A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza Vaccine [Completed]
Optimizing Influenza Vaccination in Surgical Oncology Patients [Recruiting]
Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women [Completed]
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases [Completed]
|
